Litigation Details for MITSUBISHI TANABE PHARMA CORPORATION v. MSN LABORATORIES PRIVATE LTD. (D.N.J. 2019)
✉ Email this page to a colleague
MITSUBISHI TANABE PHARMA CORPORATION v. MSN LABORATORIES PRIVATE LTD. (D.N.J. 2019)
| Docket | ⤷ Try for Free | Date Filed | 2019-10-14 |
| Court | District Court, D. New Jersey | Date Terminated | 2020-02-26 |
| Cause | 15:1126 Patent Infringement | Assigned To | Freda L. Wolfson |
| Jury Demand | None | Referred To | Douglas Arpert |
| Patents | 7,943,788 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in MITSUBISHI TANABE PHARMA CORPORATION v. MSN LABORATORIES PRIVATE LTD.
The small molecule drugs covered by the patent cited in this case are ⤷ Try for Free , ⤷ Try for Free , and ⤷ Try for Free .
Details for MITSUBISHI TANABE PHARMA CORPORATION v. MSN LABORATORIES PRIVATE LTD. (D.N.J. 2019)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2019-10-14 | External link to document | |||
| 2019-10-14 | 1 | Complaint | infringement of United States Patent No. 7,943,788 (“the ’788 patent” or “the patent-in-suit”). This action … THE PATENT-IN-SUIT 21. On May 17, 2011, the ’788 patent, titled, “Glucopyranoside… the ’788 patent. 23. JNV is an exclusive sublicensee of the ’788 patent. …date of the ’788 patent, or any later expiration of exclusivity for any of those patents to which Plaintiffs… of the ’788 patent, or any later expiration of exclusivity for any of those patents to which Plaintiffs | External link to document |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
Showing 1 to 2 of 2 entries
